ABUS

Arbutus Biopharma CorpCIK 1447028 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ABUS PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ABUS

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Nguyen Tuan	Chief Financial Officer	15	$0	$0	2026-10-01
Androski Lindsay	President and CEO, Director	14	$0	$0	2026-10-01
Sawhney Roger	Director	13	$0	$0	2026-10-01
Beardsley Robert A	Director	13	$0	$0	2026-10-01
Hasija Anuj	Director	1	$0	$0	2025-03-18
Sims Karen	Chief Medical Officer	7	$0	$73.5K	2025-02-14
McElhaugh Michael J.	Interim President & CEO	16	$0	$501.7K	2025-02-14
Naftzger J. Christopher	General Counsel and CCO	6	$0	$37.2K	2025-02-14
HASTINGS DAVID C	Chief Financial Officer	13	$0	$94.9K	2025-02-14
MANCHESTER KEITH S	Director	13	$0	$32.6K	2024-08-14
Rewolinski Melissa	Director	2	$0	$0	2024-05-23
Torti Frank	Director	7	$0	$0	2024-05-23
Meyers James R	Director	7	$0	$0	2024-05-23
BURGESS DANIEL D	Director	9	$0	$0	2024-05-23
HENRIQUES RICHARD C JR	Director	11	$7.0K	$0	2024-05-23
Sofia Michael J.	Chief Scientific Officer	23	$0	$1.75M	2024-02-02
Collier William H.	President and CEO	8	$0	$0	2023-02-01
Howard Elizabeth	Executive VP & General Counsel	9	$0	$0	2023-02-01
Tran Tram	Director	2	$0	$0	2022-05-25
Picchio Gaston	Chief Development Officer	6	$0	$0	2022-01-20
Roivant Sciences Ltd.	10% Owner	4	$116.40M	$0	2021-10-18
Cheng Andrew	Director	3	$0	$0	2021-06-03
POTTER MYRTLE S	Director	2	$0	$0	2019-08-17
Murray Mark J.	President and CEO	12	$0	$0	2019-03-01
VandenEnden Koert	Interim CFO	2	$0	$0	2018-12-11
Ramaswamy Vivek	Director, 10% Owner	4	$0	$0	2018-06-19
CONRAD HERBERT J	Director	4	$0	$0	2018-06-19
Symonds William T.	Chief Development Officer	3	$0	$0	2018-04-16
Dexcel Pharma Technologies Ltd.	10% Owner	2	$116.40M	$0	2018-01-12
SVF Holdings (UK) LLP	10% Owner	1	$66.40M	$0	2018-01-12
Lo Andrew	10% Owner	2	$116.40M	$0	2018-01-12
Ott David C.	10% Owner	1	$66.40M	$0	2018-01-12
Machado Patrick	10% Owner	2	$116.40M	$0	2018-01-12
QVT Associates GP LLC	Director, 10% Owner	2	$116.40M	$0	2018-01-12
Viking Global Equities LP	10% Owner	1	$66.40M	$0	2018-01-12
SVF GP (Jersey) Ltd	10% Owner	1	$50.00M	$0	2017-10-16
Viking Global Opportunities Portfolio GP LLC	10% Owner	1	$50.00M	$0	2017-10-16
VIKING GLOBAL PERFORMANCE LLC	10% Owner	1	$50.00M	$0	2017-10-16
KARBE FRANK	Director	3	$0	$0	2017-06-21
Lutwyche Peter	Chief Technology Officer	2	$0	$0	2017-03-24
Cousins Bruce	Exec VP & CFO	4	$0	$0	2017-03-24
Abrams Michael J.	Managing Director	6	$0	$0	2016-08-16
Kowalski Mark	Sr VP & Chief Medical Officer	1	$0	$0	2016-03-15

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Beardsley Robert A	Director	D To issuer	2026-10-01	2026-10-07	17,948	$5.00	$89.7K	14,328	SEC↗
Nguyen Tuan	Chief Financial Officer	D To issuer	2026-10-01	2026-10-07	48,081	$5.00	$240.4K	111,882	SEC↗
Sawhney Roger	Director	D To issuer	2026-10-01	2026-10-07	17,142	$5.00	$85.7K	13,683	SEC↗
Androski Lindsay	President and CEO, Director	D To issuer	2026-10-01	2026-10-07	24,655	$5.00	$123.3K	47,682	SEC↗
Beardsley Robert A	Director	M Exercise deriv	2026-09-18	2026-09-23	78,800	—	$0	0	SEC↗
Beardsley Robert A	Director	M Exercise deriv	2026-09-18	2026-09-23	52,533	—	$0	105,067	SEC↗
Sawhney Roger	Director	M Exercise deriv	2026-09-18	2026-09-23	78,800	—	$0	0	SEC↗
Sawhney Roger	Director	M Exercise deriv	2026-09-18	2026-09-23	52,533	—	$0	105,067	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise deriv	2026-09-18	2026-09-23	265,625	—	$0	484,375	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise deriv	2026-09-18	2026-09-23	27,475	—	$0	160,925	SEC↗
Androski Lindsay	President and CEO	M Exercise deriv	2026-09-18	2026-09-23	116,408	—	$0	194,014	SEC↗
Androski Lindsay	President and CEO	M Exercise deriv	2026-09-18	2026-09-23	10,456	—	$0	61,244	SEC↗
Beardsley Robert A	Director	M Exercise	2026-09-18	2026-09-23	78,800	$4.24	$334.1K	131,333	SEC↗
Beardsley Robert A	Director	M Exercise	2026-09-18	2026-09-23	52,533	$3.20	$168.1K	52,533	SEC↗
Beardsley Robert A	Director	F Tax w/h	2026-09-18	2026-09-23	99,057	$5.07	$502.2K	32,276	SEC↗
Sawhney Roger	Director	M Exercise	2026-09-18	2026-09-23	52,533	$3.34	$175.5K	52,533	SEC↗
Sawhney Roger	Director	M Exercise	2026-09-18	2026-09-23	78,800	$4.24	$334.1K	131,333	SEC↗
Sawhney Roger	Director	F Tax w/h	2026-09-18	2026-09-23	100,508	$5.07	$509.6K	30,825	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise	2026-09-18	2026-09-23	27,475	$4.39	$120.6K	366,600	SEC↗
Nguyen Tuan	Chief Financial Officer	F Tax w/h	2026-09-18	2026-09-23	206,637	$5.07	$1.05M	159,963	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise	2026-09-18	2026-09-23	265,625	$3.49	$927.0K	339,125	SEC↗
Androski Lindsay	President and CEO	M Exercise	2026-09-18	2026-09-23	10,456	$4.39	$45.9K	154,864	SEC↗
Androski Lindsay	President and CEO	F Tax w/h	2026-09-18	2026-09-23	82,527	$5.07	$418.4K	72,337	SEC↗
Androski Lindsay	President and CEO	M Exercise	2026-09-18	2026-09-23	116,408	$3.20	$372.5K	144,408	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise deriv	2026-09-18	2026-09-23	27,475	—	$0	160,925	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise deriv	2026-09-18	2026-09-23	265,625	—	$0	484,375	SEC↗
Nguyen Tuan	Chief Financial Officer	F Tax w/h	2026-09-18	2026-09-23	206,637	$5.07	$1.05M	159,963	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise	2026-09-18	2026-09-23	27,475	$4.39	$120.6K	366,600	SEC↗
Nguyen Tuan	Chief Financial Officer	M Exercise	2026-09-18	2026-09-23	265,625	$3.49	$927.0K	339,125	SEC↗
Sawhney Roger	Director	M Exercise deriv	2026-09-18	2026-09-23	78,800	—	$0	0	SEC↗
Sawhney Roger	Director	M Exercise deriv	2026-09-18	2026-09-23	52,533	—	$0	105,067	SEC↗
Sawhney Roger	Director	F Tax w/h	2026-09-18	2026-09-23	100,508	$5.07	$509.6K	30,825	SEC↗
Sawhney Roger	Director	M Exercise	2026-09-18	2026-09-23	78,800	$4.24	$334.1K	131,333	SEC↗
Sawhney Roger	Director	M Exercise	2026-09-18	2026-09-23	52,533	$3.34	$175.5K	52,533	SEC↗
Beardsley Robert A	Director	M Exercise deriv	2026-09-18	2026-09-23	78,800	—	$0	0	SEC↗
Beardsley Robert A	Director	M Exercise deriv	2026-09-18	2026-09-23	52,533	—	$0	105,067	SEC↗
Beardsley Robert A	Director	F Tax w/h	2026-09-18	2026-09-23	99,057	$5.07	$502.2K	32,276	SEC↗
Beardsley Robert A	Director	M Exercise	2026-09-18	2026-09-23	78,800	$4.24	$334.1K	131,333	SEC↗
Beardsley Robert A	Director	M Exercise	2026-09-18	2026-09-23	52,533	$3.20	$168.1K	52,533	SEC↗
Androski Lindsay	President and CEO, Director	M Exercise deriv	2026-09-18	2026-09-23	10,456	—	$0	61,244	SEC↗
Androski Lindsay	President and CEO, Director	M Exercise deriv	2026-09-18	2026-09-23	116,408	—	$0	194,014	SEC↗
Androski Lindsay	President and CEO, Director	F Tax w/h	2026-09-18	2026-09-23	82,527	$5.07	$418.4K	72,337	SEC↗
Androski Lindsay	President and CEO, Director	M Exercise	2026-09-18	2026-09-23	10,456	$4.39	$45.9K	154,864	SEC↗
Androski Lindsay	President and CEO, Director	M Exercise	2026-09-18	2026-09-23	116,408	$3.20	$372.5K	144,408	SEC↗
Beardsley Robert A	Director	A Award deriv	2026-06-08	2026-06-10	78,800	—	$0	78,800	SEC↗
Sawhney Roger	Director	A Award deriv	2026-06-08	2026-06-10	78,800	—	$0	78,800	SEC↗
Androski Lindsay	President and CEO	A Award deriv	2026-02-02	2026-02-02	71,700	—	$0	71,700	SEC↗
Nguyen Tuan	Chief Financial Officer	A Award deriv	2026-02-02	2026-02-02	188,400	—	$0	188,400	SEC↗
Androski Lindsay	President and CEO	A Award	2026-02-02	2026-02-02	28,000	—	$0	28,000	SEC↗
Nguyen Tuan	Chief Financial Officer	A Award	2026-02-02	2026-02-02	73,500	—	$0	73,500	SEC↗
Sawhney Roger	Director	A Award deriv	2025-08-04	2025-08-06	157,600	—	$0	157,600	SEC↗
Nguyen Tuan	Chief Financial Officer	A Award deriv	2025-03-31	2025-04-01	750,000	—	$0	750,000	SEC↗
Nguyen Tuan	Chief Financial Officer	A Award deriv	2025-03-31	2025-03-31	750,000	—	$0	750,000	SEC↗
Androski Lindsay	President and CEO	A Award deriv	2025-03-18	2025-03-20	310,422	—	$0	310,422	SEC↗
Beardsley Robert A	Director	A Award deriv	2025-03-18	2025-03-20	157,600	—	$0	157,600	SEC↗
Hasija Anuj	Director	A Award deriv	2025-03-18	2025-03-20	157,600	—	$0	157,600	SEC↗
Sims Karen	Chief Medical Officer	A Award deriv	2025-02-14	2025-02-19	200,300	—	$0	200,300	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2025-02-14	2025-02-19	365,800	—	$0	365,800	SEC↗
McElhaugh Michael J.	Interim President & CEO	A Award deriv	2025-02-14	2025-02-19	718,800	—	$0	718,800	SEC↗
Naftzger J. Christopher	General Counsel and CCO	A Award deriv	2025-02-14	2025-02-19	220,300	—	$0	220,300	SEC↗
Sims Karen	Chief Medical Officer	A Award	2025-02-14	2025-02-19	49,300	—	$0	155,494	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award	2025-02-14	2025-02-19	90,100	—	$0	249,824	SEC↗
McElhaugh Michael J.	Interim President & CEO	A Award	2025-02-14	2025-02-19	177,000	—	$0	1,658,003	SEC↗
Naftzger J. Christopher	General Counsel and CCO	A Award	2025-02-14	2025-02-19	54,300	—	$0	140,544	SEC↗
Naftzger J. Christopher	General Counsel and CCO	S Sale	2025-02-04	2025-02-05	11,333	$3.28	$37.2K	86,244	SEC↗
McElhaugh Michael J.	Interim President & CEO	S Sale	2025-02-04	2025-02-05	23,790	$3.28	$78.0K	1,481,003	SEC↗
Sims Karen	Chief Medical Officer	S Sale	2025-02-04	2025-02-05	19,348	$3.28	$63.5K	106,194	SEC↗
HASTINGS DAVID C	Chief Financial Officer	S Sale	2025-02-04	2025-02-05	22,183	$3.28	$72.8K	159,724	SEC↗
MANCHESTER KEITH S	Director	M Exercise deriv	2024-08-14	2024-08-16	54,915	—	$0	0	SEC↗
MANCHESTER KEITH S	Director	M Exercise	2024-08-14	2024-08-16	54,915	$0.56	$30.8K	54,915	SEC↗
MANCHESTER KEITH S	Director	S Sale	2024-08-14	2024-08-16	8,846	$3.69	$32.6K	46,069	SEC↗
Torti Frank	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
Rewolinski Melissa	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
Meyers James R	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2024-05-23	2024-05-24	67,000	—	$0	67,000	SEC↗
McElhaugh Michael J.	Interim President & CEO	S Sale	2024-02-02	2024-02-05	10,164	$2.31	$23.5K	1,504,793	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2024-02-02	2024-02-05	9,982	$2.31	$23.1K	1,485,121	SEC↗
HASTINGS DAVID C	Chief Financial Officer	S Sale	2024-02-02	2024-02-05	9,593	$2.31	$22.2K	181,907	SEC↗
Sims Karen	Chief Medical Officer	S Sale	2024-02-02	2024-02-05	4,358	$2.31	$10.1K	125,542	SEC↗
McElhaugh Michael J.	Interim President & CEO	A Award deriv	2024-02-01	2024-02-05	495,100	—	$0	495,100	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2024-02-01	2024-02-05	437,800	—	$0	437,800	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2024-02-01	2024-02-05	450,000	—	$0	450,000	SEC↗
Sims Karen	Chief Medical Officer	A Award deriv	2024-02-01	2024-02-05	403,900	—	$0	403,900	SEC↗
Naftzger J. Christopher	General Counsel and CCO	A Award deriv	2024-02-01	2024-02-05	380,500	—	$0	380,500	SEC↗
McElhaugh Michael J.	Interim President & CEO	A Award	2024-02-01	2024-02-05	123,800	—	$0	1,514,957	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award	2024-02-01	2024-02-05	109,500	—	$0	1,495,103	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award	2024-02-01	2024-02-05	112,500	—	$0	191,500	SEC↗
Sims Karen	Chief Medical Officer	A Award	2024-02-01	2024-02-05	101,000	—	$0	129,900	SEC↗
Naftzger J. Christopher	General Counsel and CCO	A Award	2024-02-01	2024-02-05	95,100	—	$0	95,100	SEC↗
Rewolinski Melissa	Director	A Award deriv	2023-07-12	2023-07-13	110,000	—	$0	110,000	SEC↗
Naftzger J. Christopher	General Counsel and CCO	A Award deriv	2023-07-10	2023-07-12	500,000	—	$0	500,000	SEC↗
Sims Karen	Chief Medical Officer	A Award deriv	2023-07-10	2023-07-12	153,640	—	$0	153,640	SEC↗
Meyers James R	Director	A Award deriv	2023-05-24	2023-05-26	55,000	—	$0	55,000	SEC↗
Torti Frank	Director	A Award deriv	2023-05-24	2023-05-26	55,000	—	$0	55,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2023-05-24	2023-05-26	55,000	—	$0	55,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2023-05-24	2023-05-26	55,000	—	$0	55,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2023-05-24	2023-05-26	55,000	—	$0	55,000	SEC↗
Howard Elizabeth	EVP, GC, Compliance	A Award deriv	2023-02-01	2023-02-03	278,700	—	$0	278,700	SEC↗
Collier William H.	President and CEO	A Award deriv	2023-02-01	2023-02-03	866,000	—	$0	866,000	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2023-02-01	2023-02-03	316,000	—	$0	316,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2023-02-01	2023-02-03	328,700	—	$0	328,700	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award deriv	2023-02-01	2023-02-03	334,700	—	$0	334,700	SEC↗
Howard Elizabeth	EVP, GC, Compliance	A Award	2023-02-01	2023-02-03	69,700	—	$0	86,024	SEC↗
Collier William H.	President and CEO	A Award	2023-02-01	2023-02-03	216,500	—	$0	216,500	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award	2023-02-01	2023-02-03	79,000	—	$0	79,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award	2023-02-01	2023-02-03	82,200	—	$0	1,385,603	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award	2023-02-01	2023-02-03	83,700	—	$0	1,391,157	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
Tran Tram	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
Torti Frank	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
Meyers James R	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2022-05-25	2022-05-26	41,000	—	$0	41,000	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award deriv	2022-01-20	2022-01-20	325,850	$2.81	$915.6K	325,850	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2022-01-20	2022-01-20	256,500	$2.81	$720.8K	256,500	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2022-01-20	2022-01-20	285,000	$2.81	$800.9K	285,000	SEC↗
Howard Elizabeth	Chief Compliance Officer	A Award deriv	2022-01-20	2022-01-20	237,500	$2.81	$667.4K	237,500	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2022-01-20	2022-01-20	285,000	$2.81	$800.9K	285,000	SEC↗
Collier William H.	President and CEO	A Award deriv	2022-01-20	2022-01-20	787,550	$2.81	$2.21M	787,550	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2021-12-01	2021-12-03	200,000	$5.09	$1.02M	1,303,403	SEC↗
Tran Tram	Director	A Award deriv	2021-11-09	2021-11-12	44,000	—	$0	44,000	SEC↗
Roivant Sciences Ltd.	10% Owner	C Conversion deriv	2021-10-18	2021-10-20	1,164,000	—	$0	0	SEC↗
Roivant Sciences Ltd.	10% Owner	C Conversion	2021-10-18	2021-10-20	22,833,922	—	$0	38,847,462	SEC↗
Torti Frank	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
Cheng Andrew	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
Meyers James R	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2021-06-03	2021-06-07	22,000	—	$0	22,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2021-02-13	2021-02-17	290,000	—	$0	290,000	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award deriv	2021-02-13	2021-02-17	249,000	—	$0	249,000	SEC↗
Howard Elizabeth	Chief Compliance Officer	A Award deriv	2021-02-13	2021-02-17	200,000	—	$0	200,000	SEC↗
Collier William H.	President and CEO	A Award deriv	2021-02-13	2021-02-17	675,000	—	$0	675,000	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2021-02-13	2021-02-17	250,000	—	$0	250,000	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2021-02-13	2021-02-17	250,000	—	$0	250,000	SEC↗
McElhaugh Michael J.	Chief Business Officer	S Sale	2021-02-09	2021-02-10	20,000	$5.00	$100.0K	1,307,457	SEC↗
McElhaugh Michael J.	Chief Business Officer	S Sale	2020-12-14	2020-12-16	30,000	$5.00	$150.0K	1,337,457	SEC↗
McElhaugh Michael J.	Chief Business Officer	S Sale	2020-12-14	2020-12-16	10,000	$5.00	$50.0K	1,327,457	SEC↗
Collier William H.	President and CEO	A Award deriv	2020-09-23	2020-09-25	70,000	—	$0	70,000	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2020-09-23	2020-09-25	50,000	—	$0	50,000	SEC↗
McElhaugh Michael J.	Chief Business Officer	S Sale	2020-07-23	2020-07-27	20,000	$5.01	$100.2K	1,367,457	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
Cheng Andrew	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
Torti Frank	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
Collier William H.	President and CEO	A Award deriv	2020-05-28	2020-06-01	262,313	—	$0	262,313	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
Meyers James R	Director	A Award deriv	2020-05-28	2020-06-01	22,000	—	$0	22,000	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award deriv	2020-02-17	2020-02-19	200,000	—	$0	200,000	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2020-02-17	2020-02-19	100,000	—	$0	100,000	SEC↗
Collier William H.	President and CEO	A Award deriv	2020-02-17	2020-02-19	367,087	—	$0	367,087	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2020-02-17	2020-02-19	150,000	—	$0	150,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2020-02-17	2020-02-19	250,000	—	$0	250,000	SEC↗
Howard Elizabeth	Chief Compliance Officer	A Award deriv	2020-02-17	2020-02-19	79,500	—	$0	79,500	SEC↗
Torti Frank	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
Meyers James R	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
POTTER MYRTLE S	Director	A Award deriv	2019-08-17	2019-08-20	22,000	—	$0	22,000	SEC↗
Cheng Andrew	Director	A Award deriv	2019-08-17	2019-08-20	60,000	—	$0	60,000	SEC↗
Collier William H.	President and CEO	A Award deriv	2019-06-24	2019-06-26	1,112,000	—	$0	1,112,000	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2019-03-01	2019-03-05	137,500	—	$0	137,500	SEC↗
Howard Elizabeth	Executive VP & General Couns	A Award deriv	2019-03-01	2019-03-05	137,500	—	$0	137,500	SEC↗
Murray Mark J.	President and CEO	A Award deriv	2019-03-01	2019-03-05	357,500	—	$0	357,500	SEC↗
McElhaugh Michael J.	Chief Business Officer	A Award deriv	2019-03-01	2019-03-05	104,500	—	$0	104,500	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2019-03-01	2019-03-05	145,000	—	$0	145,000	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2019-03-01	2019-03-05	137,500	—	$0	137,500	SEC↗
VandenEnden Koert	Chief Accounting Officer	A Award deriv	2018-12-11	2018-12-13	7,500	—	$0	7,500	SEC↗
Murray Mark J.	Director	M Exercise deriv	2018-11-28	2018-11-30	25,000	—	$0	0	SEC↗
Murray Mark J.	Director	M Exercise	2018-11-28	2018-11-30	25,000	$1.35	$33.8K	341,396	SEC↗
Torti Frank	Director	A Award deriv	2018-11-26	2018-11-27	44,000	—	$0	44,000	SEC↗
Meyers James R	Director	A Award deriv	2018-10-18	2018-10-22	44,000	—	$0	44,000	SEC↗
POTTER MYRTLE S	Director	A Award deriv	2018-10-18	2018-10-22	44,000	—	$0	44,000	SEC↗
Picchio Gaston	Chief Development Officer	A Award deriv	2018-10-08	2018-10-10	200,000	—	$0	200,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-08-13	2018-08-14	4,250	$9.51	$40.4K	1,499,153	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-08-13	2018-08-15	4,250	$9.51	$40.4K	167,162	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-07-11	2018-07-13	10,000	$10.00	$100.0K	1,503,403	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-07-09	2018-07-10	10,000	$8.91	$89.1K	1,513,403	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-07-06	2018-07-10	10,000	$8.45	$84.5K	1,523,403	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-07-05	2018-07-06	10,000	$8.40	$84.0K	1,533,403	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2018-07-03	2018-07-06	10,000	$8.00	$80.0K	1,543,403	SEC↗
HASTINGS DAVID C	Chief Financial Officer	A Award deriv	2018-06-19	2018-06-21	200,000	—	$0	200,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2018-06-19	2018-06-22	22,000	—	$0	22,000	SEC↗
Ramaswamy Vivek	Director	A Award deriv	2018-06-19	2018-06-22	22,000	—	$0	22,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2018-06-19	2018-06-22	22,000	—	$0	22,000	SEC↗
CONRAD HERBERT J	Director	A Award deriv	2018-06-19	2018-06-22	22,000	—	$0	22,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2018-06-19	2018-06-25	22,000	—	$0	22,000	SEC↗
Murray Mark J.	President & CEO	M Exercise deriv	2018-04-17	2018-04-17	27,007	—	$0	0	SEC↗
Murray Mark J.	President & CEO	M Exercise	2018-04-17	2018-04-17	27,007	$0.35	$9.5K	316,396	SEC↗
Howard Elizabeth	Exec. VP & General Counsel	A Award deriv	2018-04-16	2018-04-17	150,000	—	$0	150,000	SEC↗
Symonds William T.	Chief Development Officer	A Award deriv	2018-04-16	2018-04-17	30,000	—	$0	30,000	SEC↗
VandenEnden Koert	Interim CFO	A Award deriv	2018-04-16	2018-04-17	25,000	—	$0	25,000	SEC↗
Murray Mark J.	President & CEO	A Award deriv	2018-04-16	2018-04-17	418,187	—	$0	418,187	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2018-04-16	2018-04-18	160,000	—	$0	160,000	SEC↗
Machado Patrick	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Roivant Sciences Ltd.	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Lo Andrew	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Viking Global Equities LP	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Ott David C.	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
QVT Associates GP LLC	Director, 10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Dexcel Pharma Technologies Ltd	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
SVF Holdings (UK) LLP	10% Owner	P Buy deriv	2018-01-12	2018-01-16	664,000	$100.00	$66.40M	1,164,000	SEC↗
Machado Patrick	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
Roivant Sciences Ltd.	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
Lo Andrew	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
VIKING GLOBAL PERFORMANCE LLC	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
Viking Global Opportunities Po	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
SVF GP (Jersey) Ltd	10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
QVT Associates GP LLC	Director, 10% Owner	P Buy deriv	2017-10-16	2017-10-17	500,000	$100.00	$50.00M	500,000	SEC↗
Dexcel Pharma Technologies Ltd	10% Owner	P Buy deriv	2017-10-16	2017-10-18	500,000	$100.00	$50.00M	500,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2017-10-03	2017-10-05	10,000	$8.00	$80.0K	1,553,403	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2017-08-15	2017-08-17	10,000	$3.75	$37.5K	191,412	SEC↗
Sofia Michael J.	Chief Scientific Officer	S Sale	2017-08-15	2017-08-17	20,000	$3.68	$73.6K	171,412	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2017-06-21	2017-06-22	22,000	—	$0	22,000	SEC↗
CONRAD HERBERT J	Director	A Award deriv	2017-06-21	2017-06-22	22,000	—	$0	22,000	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2017-06-21	2017-06-22	22,000	—	$0	22,000	SEC↗
KARBE FRANK	Director	A Award deriv	2017-06-21	2017-06-23	22,000	—	$0	22,000	SEC↗
Ramaswamy Vivek	Director	A Award deriv	2017-06-21	2017-06-23	22,000	—	$0	22,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2017-06-21	2017-06-23	22,000	—	$0	22,000	SEC↗
Symonds William T.	Chief Development Officer	A Award deriv	2017-03-24	2017-04-05	50,000	—	$0	50,000	SEC↗
Cousins Bruce	EVP & Chief Financial Office	A Award deriv	2017-03-24	2017-04-05	200,000	—	$0	200,000	SEC↗
Howard Elizabeth	Exec. VP & General Counsel	A Award deriv	2017-03-24	2017-04-05	125,000	—	$0	125,000	SEC↗
Lutwyche Peter	Chief Technology Officer	A Award deriv	2017-03-24	2017-04-05	125,000	—	$0	125,000	SEC↗
Murray Mark J.	President & CEO	A Award deriv	2017-03-24	2017-04-05	450,000	—	$0	450,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2017-03-24	2017-04-05	150,000	—	$0	150,000	SEC↗
BURGESS DANIEL D	Director	A Award deriv	2017-03-24	2017-03-27	50,000	—	$0	50,000	SEC↗
Abrams Michael J.	Managing Director	M Exercise deriv	2016-08-16	2016-08-18	675	—	$0	0	SEC↗
Abrams Michael J.	Managing Director	M Exercise deriv	2016-08-16	2016-08-18	13,503	—	$0	0	SEC↗
Abrams Michael J.	Managing Director	M Exercise	2016-08-16	2016-08-18	14,178	$0.35	$5.0K	42,097	SEC↗
Murray Mark J.	President & CEO	X Exercise deriv	2016-06-16	2016-06-20	5,000	—	$0	0	SEC↗
Murray Mark J.	President & CEO	X Exercise	2016-06-16	2016-06-20	5,000	$2.57	$12.8K	289,389	SEC↗
KARBE FRANK	Director	A Award deriv	2016-06-03	2016-06-07	7,500	—	$0	7,500	SEC↗
CONRAD HERBERT J	Director	A Award deriv	2016-06-03	2016-06-07	7,500	—	$0	7,500	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2016-06-03	2016-06-07	7,500	—	$0	7,500	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2016-06-03	2016-06-07	7,500	—	$0	7,500	SEC↗
Ramaswamy Vivek	Director, 10% Owner	A Award deriv	2016-06-03	2016-06-07	7,500	—	$0	7,500	SEC↗
Abrams Michael J.	Managing Director	A Award deriv	2016-03-15	2016-03-17	50,000	—	$0	50,000	SEC↗
Cousins Bruce	Exec VP & CFO	A Award deriv	2016-03-15	2016-03-17	145,000	—	$0	145,000	SEC↗
Kowalski Mark	Sr VP & Chief Medical Office	A Award deriv	2016-03-15	2016-03-17	85,000	—	$0	85,000	SEC↗
Lutwyche Peter	Chief Tech. Operations Offic	A Award deriv	2016-03-15	2016-03-17	60,000	—	$0	60,000	SEC↗
Murray Mark J.	President & CEO	A Award deriv	2016-03-15	2016-03-17	450,000	—	$0	450,000	SEC↗
Sofia Michael J.	Chief Scientific Officer	A Award deriv	2016-03-15	2016-03-17	100,000	—	$0	100,000	SEC↗
Howard Elizabeth	Exec. VP & General Counsel	A Award deriv	2016-03-15	2016-03-17	120,000	—	$0	120,000	SEC↗
Symonds William T.	Chief Development Officer	A Award deriv	2016-03-15	2016-03-17	25,000	—	$0	25,000	SEC↗
HENRIQUES RICHARD C JR	Director	P Buy	2015-08-24	2015-08-26	1,000	$6.95	$7.0K	1,000	SEC↗
MANCHESTER KEITH S	Director	A Award deriv	2015-08-12	2015-08-14	7,500	—	$0	7,500	SEC↗
Ramaswamy Vivek	Director, 10% Owner	A Award deriv	2015-08-12	2015-08-14	7,500	—	$0	7,500	SEC↗
CONRAD HERBERT J	Director	A Award deriv	2015-08-12	2015-08-14	7,500	—	$0	7,500	SEC↗
HENRIQUES RICHARD C JR	Director	A Award deriv	2015-08-12	2015-08-14	7,500	—	$0	7,500	SEC↗
KARBE FRANK	Director	A Award deriv	2015-08-12	2015-08-14	7,500	—	$0	7,500	SEC↗
Abrams Michael J.	Managing Director	A Award deriv	2015-07-09	2016-01-06	35,000	—	$0	35,000	SEC↗
Cousins Bruce	EVP & CFO	A Award deriv	2015-07-09	2016-01-06	75,000	—	$0	75,000	SEC↗
Murray Mark J.	President & CEO	A Award deriv	2015-07-09	2016-01-06	100,000	—	$0	100,000	SEC↗
Abrams Michael J.	Exec. VP & Chief Discovery O	A Award deriv	2015-07-09	2015-12-22	35,000	—	$0	35,000	SEC↗
Cousins Bruce	Exec VO & CFO	A Award deriv	2015-07-09	2015-12-22	75,000	—	$0	75,000	SEC↗
Murray Mark J.	President & CEO	A Award deriv	2015-07-09	2015-12-22	100,000	—	$0	100,000	SEC↗